Analysts highlighted bullish calls and raised price targets for AbbVie, Moderna, and Eli Lilly amid sector optimism.

The entities involved

• AbbVie →

  pharmaceutical company

  • OpenSecrets tracked donations to Virginia Foxx, who held stocks in AbbVie, in North Carolina.00:49
  • AbbVie, Amgen, Micron Technology, and NetApp all showed strength in the stock market on October 7, 2026.Wed 17:11
• Moderna →

  American biotechnology company

  • Australian researchers announced a global cancer vaccine breakthrough on August 20, 2026, which subsequently boosted Moderna's share price.Tue 13:21
  • Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations.Tue 01:49
• Eli Lilly and Company →

  American pharmaceutical company

  • Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.Wed 17:08
  • Acquisition of ImClone Systems provided an oncology franchise.Wed 14:57

Related events

• Berenberg Bank raised a price target and gave a 'hold' rating on Eli Lilly and Company, alongside filing required reports with the SEC.Jun 7
• Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.Jul 9
• Financial results and stock performance comparisons among AbbVie, Johnson & Johnson, Eli Lilly, and Merck.Aug 14
• AbbVie is listed on the Nasdaq stock exchange, and MarketBeat is reporting on its stock performance.Sep 4